Literature DB >> 17828505

Expression of hTERT, p53 and PCNA in cystitis glandularis.

Zhifeng Wei1, Zhangqun Ye, Zhiqiang Chen.   

Abstract

To examine the expression of human telomere reverse transcriptase (hTERT), p53 and proliferating cell nuclear antigen (PCNA) in cystitis glandularis, 38 patients were divided into two groups: group A (including 18 cases of papillary cystitis glandularis) and group B (including 20 subjects with normal bladder mucosa). All the cases were immunohistochemically examined by using antibodies specifically against p53 and PCNA, and hTERT was determined by in situ hybridization. hTERT was found in 6 cases (33.3%) and p53 was detected in 4 cases (22.2%) in group A, while they were not detected in group B. There were significant differences in hTERT and p53 expression between groups A and B (P<0.05 for both). PCNA was detected in 7 cases (38.9%) in group A and 1 case (5.0%) in group B, and significant difference in PCNA expression was found between the two groups (P<0.05). The expressions of hTERT, p53 and PCNA were significantly higher in group A than in group B, suggesting that papillary cystitis glandularis is predisposed to cancerous change, and p53, PCNA, hTERT may be related to the malignant alteration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17828505     DOI: 10.1007/s11596-007-0422-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  11 in total

1.  Transition of cystitis glandularis to primary adenocarcinoma of the bladder.

Authors:  J L SHAW; G J GISLASON; J E IMBRIGLIA
Journal:  J Urol       Date:  1958-05       Impact factor: 7.450

Review 2.  Telomeres, telomerase, and immortality.

Authors:  M S Rhyu
Journal:  J Natl Cancer Inst       Date:  1995-06-21       Impact factor: 13.506

3.  Human telomerase contains evolutionarily conserved catalytic and structural subunits.

Authors:  L Harrington; W Zhou; T McPhail; R Oulton; D S Yeung; V Mar; M B Bass; M O Robinson
Journal:  Genes Dev       Date:  1997-12-01       Impact factor: 11.361

4.  Telomerase activity as a potential marker in preneoplastic bladder lesions.

Authors:  F Lancelin; M Anidjar; J M Villette; A Soliman; P Teillac; A Le Duc; J Fiet; O Cussenot
Journal:  BJU Int       Date:  2000-03       Impact factor: 5.588

5.  Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.

Authors:  M Takakura; S Kyo; T Kanaya; M Tanaka; M Inoue
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

6.  Florid cystitis glandularis of intestinal type with mucin extravasation: a mimic of adenocarcinoma.

Authors:  R H Young; D G Bostwick
Journal:  Am J Surg Pathol       Date:  1996-12       Impact factor: 6.394

7.  The prevalence and distribution of proliferative and metaplastic changes in normal appearing canine bladders.

Authors:  A L Lage; N A Gillett; R F Gerlach; E N Allred
Journal:  J Urol       Date:  1989-04       Impact factor: 7.450

8.  The prevalence and significance of Brunn's nests, cystitis cystica and squamous metaplasia in normal bladders.

Authors:  D P Wiener; L G Koss; B Sablay; S Z Freed
Journal:  J Urol       Date:  1979-09       Impact factor: 7.450

9.  The role of beta-catenin signaling in the malignant potential of cystitis glandularis.

Authors:  R T Bryan; J H Nicholls; R F Harrison; J A Jankowski; D M A Wallace
Journal:  J Urol       Date:  2003-11       Impact factor: 7.450

10.  p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.

Authors:  D Esrig; C H Spruck; P W Nichols; B Chaiwun; K Steven; S Groshen; S C Chen; D G Skinner; P A Jones; R J Cote
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

View more
  1 in total

1.  CircTHBS1 targeting miR-211/CCND2 pathway to promote cell proliferation and migration potential in primary cystitis glandularis cells.

Authors:  Yue Ma; Zhengfei Shan; Ying Liu; Honggang Shao; Yupeng Xin; Kai He; Shichun Jiang; Yaodong Wang
Journal:  Biosci Rep       Date:  2021-08-27       Impact factor: 3.840

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.